Polymer Micropatches as B-Cell Engagers
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c04385 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Supriya Prakash und 5 weiteren Autor:innen. Beteiligte Einrichtung: Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, Massachusetts 02134, United States. Hauptthemen laut MEDLINE: B-Lymphocytes, CD40 Antigens, Polymers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Science Foundation Graduate Research Fellowship Program, Hansjörg Wyss Institute for Biologically Inspired Engineering, Harvard University, Harvard School of Engineering and Applied Sciences.
Abstract (Originalsprache)
B cells, despite their several unique functionalities, remain largely untapped for use as an adoptive cell therapy and are limited to in vitro use for antibody production. B cells can be easily sourced, they possess excellent lymphoid-homing capabilities, and they can act as antigen-presenting cells (APCs), offering an alternative to dendritic cells (DCs), which have shown limited efficacy in the clinical setting. Soluble factors such as IL-4 and anti-CD40 antibody can enhance the activation, survival, and antigen-presenting capabilities of B cells; however, it is difficult to attain sufficiently high concentrations of these biologics to stimulate B cells in vivo. Micropatches as Cell Engagers (MACE) are polymeric microparticles, surface functionalized with anti-CD40 and anti-IgM, which can attach to B cells and simultaneously engage multiple B-cell receptors (BCR) and CD40 receptors. Stimulation of these receptors through MACE, unlike free antibodies, enhanced the display of costimulatory molecules on the B-cell surface, increased B-cell viability, and improved antigen presentation by B cells to T cells in vitro. B-cell activation by MACE further synergized with soluble IL-4 and anti-CD40. MACE also elicited T-cell chemokine secretion by B cells. Upon intravenous adoptive transfer, MACE-bound B cells homed to the spleen and lymph nodes, key sites for antigen presentation to T cells. Adoptive transfer of MACE-B cells pulsed with the CD4+ and CD8+ epitopes of ovalbumin significantly delayed tumor progression in a murine subcutaneous EG7-OVA tumor model, demonstrating the functional benefit conferred to B cells by MACE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, Massachusetts 02134, United States.
- Wyss Institute for Biologically Inspired Engineering, Boston, Massachusetts 02115, United States.
- Harvard-MIT Program in Health Science and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
ORCID-Profile: Supriya Prakash, Samir Mitragotri
Förderung
- National Science Foundation Graduate Research Fellowship Program
- Hansjörg Wyss Institute for Biologically Inspired Engineering, Harvard University
- Harvard School of Engineering and Applied Sciences
Zitieren
APA
Prakash, S., Kumbhojkar, N., Gottlieb, A. P., Park, K. S., Kapate, N., & Mitragotri, S. (2024). Polymer Micropatches as B-Cell Engagers. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c04385
Vancouver
Prakash S, Kumbhojkar N, Gottlieb AP, Park KS, Kapate N, Mitragotri S. Polymer Micropatches as B-Cell Engagers. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c04385
BibTeX
@article{Prakash2024,
author = {Prakash, Supriya and Kumbhojkar, Ninad and Gottlieb, Alexander P and Park, Kyung-Soo and Kapate, Neha and Mitragotri, Samir},
title = {Polymer Micropatches as B-Cell Engagers},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c04385}
}
EUVIMED